Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

NCT07746934 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Metronidazole
DRUG: Tinidazole 500mg
DRUG: tetracyline
DRUG: Bismuth Subcitrate
DRUG: esomeprazole 40 mg

Sponsor

University of Medicine and Pharmacy at Ho Chi Minh City